Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaspan in Diabetic Nephropathy
NCT00108485Phase 3Terminated
- Sponsor
- University of Miami
- Start
- Apr 2005
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niacin in diabetic nephropathy (DN), hyperlipidemia, sponsored by University of Miami. Started Apr 2005; status: terminated.
02
Drugs
niacin
03
Conditions
diabetic nephropathy (DN)hyperlipidemia
Beyond the preview
Go deeper on NCT00108485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108485.